Global vaso occlusive crisis associated with sickle cell disease market is anticipated to grow at a considerable CAGR during the forecast period (2022-2028). The key companies operating in the industry are highly inclined towards the adoption of different growth strategies including capacity expansion, partnerships, mergers, and acquisitions, geographical expansions, and product innovations to remain competitive in the market. For instance, in September 2019, the US Government and Gates Foundation have pledged $200 million to bring gene therapy to patients with sickle diseases. The collaboration between the National Institute of Health (NIH) and the Gates Foundation aimed at ensuring effective, safe, and durable gene-based therapy cures in the US and relevant countries in sub-Saharan Africa.
To Request a Sample of our Report on Global Vaso Occlusive crisis Associated with Sickle Cell Disease Market: https://www.omrglobal.com/request-sample/vaso-occlusive-crisis-associated-with-the-sickle-cell-disease-market
Moreover, in 2020, according to the National Institute of Health, the US Food and Drug Administration, pharmaceutical companies and non-profit organizations have partnered to accelerate the development of gene-based therapies for 30 million Americans who suffer from a rare disease. Product launches and approvals are expected to boost the market during the forecast period. For instance, in June 2020, Emmaus Medcial Inc. has received approval from the Israeli Ministry of Health for the commercial distribution of Endari in Israel. Endari is a Glutamine oral powder used to treat acute complications of sickle diseases in adults and children age 5 years and older. Moreoever, in October 2020, Medunik USa Inc. launched Siklos for pediatric patients with sickle cell diseases. Siklos is a film-coated tablet, that is used to reduce vaso occlusive crisis caused by sickle cell disease.
Market Coverage
- The market number available for – 2021-2028
- Base year- 2021
- Forecast period- 2022-2028
Segment Covered-
- By Type
- By Application
Regions Covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape- Novartis AG, AstraZeneca Plc., Medunik USA Inc., Bristol-Myers Squibb Co, Emmaus Medical Inc., and more
(Get 15% Discount on Buying this Report)
A full Report of Global Vaso Occlusive crisis Associated with Sickle Cell Disease Market is Available @ https://www.omrglobal.com/industry-reports/vaso-occlusive-crisis-associated-with-the-sickle-cell-disease-market
Global Vaso Occlusive Crisis Associated with Sickle Cell disease Market Report Segment
By Type
- Crizanlizumab
- SGD-2083
- NVX-508
- PF-04447943
By Application
- Hospital
- Clinic
Global Vaso occlusive crisis associated with sickle cell disease Market Report Segment by Region
North America
- United States
- Canada
Europe
- UK
- Germany
- Spain
- France
- Italy
- Rest of Europe
Asia-Pacific
- India
- China
- Japan
- South Korea
- Rest of APAC
Rest of the World
- Latin America
- Middle East & Africa
Company Profiles
- Alnylam Pharmaceuticals, Inc.
- Arena Pharmaceuticals, Inc
- Acceleron Pharma, Inc. (Merck &Co.)
- Bluebird bio, Inc.
- Baxter International, Inc.
- Daiichi Sankyo Co.
- Dr.Reddy’s Laboratories, Ltd.
- Eli Lilly &Co.
- Global Blood Therapeutics, Inc.
- Johnson & Johnson Services, Inc.
- SANOFI
- Sangamo Therapeutics, Inc.
- Takeda Pharmacuetical Co, Ltd.
- Teva Pharmaceutical Industries Ltd.
Reasons to buy from us –
- We cover more than 15 major industries, further segmented into more than 90 sectors.
- More than 120 countries are for analysis.
- Over 100+ paid data sources mined for investigation.
- Our expert research analysts answer all your questions before and after purchasing your report.
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.
Media Contact:
Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: info@omrglobal.com
Contact no: +91 7803040404
